Directorate Change
Non-Executive Director Bob Beveridge retiring after nine years; Richard Jones appointed as replacement NED and Audit Committee Chair.
Select text to share a quote on X · sign in to keep highlights & notes in your IHC notes
Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company pioneering best-in-class, specialist neonatal intensive care medical devices, announces the retirement of Bob Beveridge, Non-Executive Director ("NED") who is stepping down after nine years in line with best practice. Bob will be replaced as NED and Chair of the Audit Committee by Richard Jones. The Board wish to thank Bob for his years of service and commitment to Inspiration Healthcare during his tenure and are delighted to be able to appoint Richard to the role. Both changes will come into effect from 31 January 2025.
Richard is a seasoned healthcare and life sciences professional with extensive experience as a board member of publicly listed companies. He has spent more than 20 years serving in both independent NED and Executive Director roles and has acted as a key adviser across a diverse range of public and private companies in the life sciences space. He has expertise across a wide spectrum of Board issues and has worked extensively outside the UK PLC market having completed a US reverse merger as CFO for a UK biotech company in 2019.
Currently he is a Senior Independent Director and Audit Committee Chair of Alliance Pharma PLC, an AIM listed international consumer healthcare company where he is closely involved in all aspects of the business. Formerly, he was Chief Financial Officer ("CFO") and Company Secretary of the UK and Ireland's leading supplier of tele-radiology services, Medica Group Ltd. His CFO and Board experience also includes Mereo Biopharma PLC and Shield Therapeutics PLC.
Roy Davis, Executive Chairman of Inspiration Healthcare said: "We are delighted to welcome Richard on board, and we are excited to be able to tap into his extensive capital markets experience, as well as his in-depth knowledge of the US market where we continue to grow our presence.
"On behalf of the Board, I would like to thank Bob for his dedication and commitment to Inspiration Healthcare over almost a decade. We will be sad to see him go, and we wish him all the very best for his future plans."
Bob Beveridge, outgoing Non-Executive Director said: "I have thoroughly enjoyed my time with the Inspiration Healthcare team over the years. I believe they are at a key transitional phase, and I know they will be a great success. I wish them well for a bright future."
Richard Jones, incoming Non-Executive Director added: "I am looking forward to joining the Board of Inspiration Healthcare and sharing my PLC and life sciences industry expertise with the team."
In accordance with Schedule 2 (g) of the AIM Rules for Companies, Richard Crispin Morgan Jones (aged 58 years) holds / has held the following directorships/partnerships in the last five years:
| Current directorships / partnerships | Previous directorships / partnerships in last 5 years |
| Alliance Pharma plc | Global Diagnostics Ireland Ltd |
| C4X Discovery Holdings Limited | Global Retinopathy Screening Ltd |
| Hampshire Topco Limited | JCA Seminars Limited |
| Hero Acquisitions Limited | Medica Australia Pty Ltd |
| HSS Hire Group plc | Medica Group Limited |
| HSS Hire Service Finance Limited | Medica IT Services Limited |
| RCMJ Consultancy Ltd | Medica Reporting Finance Limited |
Medica Reporting Limited
Medica Reporting Services Limited
Medica US Inc
Med-IDX Pty Ltd
Med-IDX UK Limited
Mereo Biopharma 1 Limited
Mereo Biopharma 2 Limited
Mereo Biopharma 3 Limited
Mereo Biopharma 4 Limited
Mereo Biopharma Group plc
Mereo BioPharma Ireland Limited
Mereo MereoCo Inc
Mereo US Holdings Inc
Moonlight Bidco Limited
Moonlight Midco 1 Limited
Moonlight Midco 2 Limited
Moonlight Topco Limited
Richard Crispin Morgan Jones does not hold any ordinary shares in the capital of the Company. There are no further disclosures to be made in accordance with AIM Rule 17 or Schedule 2(g) of the AIM Rules for Companies.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.